TY - JOUR
T1 - Recent advances in diagnostic strategies for giant cell arteritis
AU - Kermani, Tanaz A.
AU - Warrington, Kenneth J.
N1 - Funding Information:
Disclosure Conflicts of interest: T.A. Kermani: was supported by the Vasculitis Clinical Research Consortium (VCRC), which has received support from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (U54AR057319), the National Center for Research Resources (U54 RR019497), and the Office of Rare Diseases Research. The VCRC is part of the Rare Diseases Clinical Research Network (RDCRN); K.J. Warrington: none.
PY - 2012/4
Y1 - 2012/4
N2 - Giant cell arteritis (GCA) is a systemic vasculitis that affects the aorta and its major branches. Involvement of the ciliary artery can result in ischemic optic neuropathy and subsequent blindness, which is typically irreversible. If GCA is suspected, treatment with glucocorticoids should be initiated promptly to prevent further vision loss. However, given the need for prolonged therapy with glucocorticoids and the morbidity associated with their use, diagnosis should be confirmed. Clinical features and laboratory findings are neither sensitive nor specific for GCA. The mainstay of diagnosis remains histopathologic examination of a section of the superficial temporal artery. Several imaging studies have been used to evaluate the temporal artery but, at present, their utility as alternatives to a temporal artery biopsy is limited. Recent advances in imaging modalities have allowed detailed noninvasive imaging of the large arteries and are a useful adjunct for the diagnosis of GCA, particularly in patients with primarily large-vessel involvement in whom temporal artery biopsy is often negative.
AB - Giant cell arteritis (GCA) is a systemic vasculitis that affects the aorta and its major branches. Involvement of the ciliary artery can result in ischemic optic neuropathy and subsequent blindness, which is typically irreversible. If GCA is suspected, treatment with glucocorticoids should be initiated promptly to prevent further vision loss. However, given the need for prolonged therapy with glucocorticoids and the morbidity associated with their use, diagnosis should be confirmed. Clinical features and laboratory findings are neither sensitive nor specific for GCA. The mainstay of diagnosis remains histopathologic examination of a section of the superficial temporal artery. Several imaging studies have been used to evaluate the temporal artery but, at present, their utility as alternatives to a temporal artery biopsy is limited. Recent advances in imaging modalities have allowed detailed noninvasive imaging of the large arteries and are a useful adjunct for the diagnosis of GCA, particularly in patients with primarily large-vessel involvement in whom temporal artery biopsy is often negative.
KW - Computed tomography angiography
KW - Diagnosis
KW - Giant cell arteritis
KW - Large-vessel vasculitis
KW - Magnetic resonance angiography
KW - Positron emission Tomography
KW - Temporal arteritis
KW - Temporal artery biopsy
KW - Ultrasonography
UR - http://www.scopus.com/inward/record.url?scp=84861233643&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84861233643&partnerID=8YFLogxK
U2 - 10.1007/s11910-011-0243-6
DO - 10.1007/s11910-011-0243-6
M3 - Article
C2 - 22205235
AN - SCOPUS:84861233643
SN - 1528-4042
VL - 12
SP - 138
EP - 144
JO - Current Neurology and Neuroscience Reports
JF - Current Neurology and Neuroscience Reports
IS - 2
ER -